Biotech Values

[WorstLuck]

worried about the quarterlies at this stage

When it finally starts gapping up, it will be over fast.

Seems like you are relying on CD approval for price enhancement. But CD approval is mostly baked in. The only real question is how good the label is - and it should be at least adequate. Yeah, yeah ... stuff has happened and may happen again. Approval is not assured. But absent a best-possible label, CD approval is a sell-the-news event.

You really should be focusing on sales. That is where price is at for the next few quarters, at least. I can understand someone with a multi-year time frame not having an overriding interest in the upcoming earnings call but that isn't me and it doesn't sound like you.